# Antibiotic medicines: Working

Source page: https://www.materialinsights.org/products/p_antibiotic_medicines/prod-working/

#### What it is

The product and the job it does, in a short paragraph

Antibiotic medicines are finished medicines that act against bacteria, sold for people as tablets, capsules ^[24], powder oral suspensions ^[15] and injections. The functional unit is one course of treatment, meaning one full prescribed course; its length depends on the infection and is not given here. Penicillins, streptomycins and other antibiotics are counted. Medicines for animals and plants, antivirals, bulk ingredients and prescribing advice are left out.

as of 2026-11-14

#### How it works

How it does its job, step by step in plain words

An antibiotic medicine starts as an active ingredient, often built from intermediates such as 6-APA and 7-ACA ^[2]^[16]. WHO's guidance covers every step from making the active ingredient to formulating finished products, including primary packaging ^[1]. In India, antibiotics are sold by retail only on a registered medical practitioner's prescription ^[17]. WHO sorts antibiotics into Access, Watch and Reserve groups, and countries committed in 2024 that Access antibiotics would make up at least 70% of use by 2030 ^[8]. Resistance limits how long an antibiotic stays useful: WHO found one in six confirmed bacterial infections resistant in 2023 ^[6].

as of 2026-11-14

#### Key specifications

The numbers that describe it, each with unit, variant, year and source

| Spec | Value | Unit | Year | Source |
|---|---|---|---|---|
| Strength of the azithromycin tablet in the NPPA ceiling-price order (example presentation) | 500 | mg | 2024 | ^[19] |
| Ceiling price of that azithromycin 500 mg tablet, per tablet | 11.67 | Rs per tablet | 2024 | ^[19] |
| UNICEF indicative price of one treatment course of amoxicillin dispersible tablets for a child under one year | 0.22 | US$ per course | 2018 | ^[10] |
| Production capacity of Sandoz's Kundl site, finished dosage forms (company statement reported by a trade publication) | 240 million | packages per year | 2024 | ^[15] |

as of 2026-11-14

#### Limits

The physical limits set by science and the engineering limits of today's design, with today's value

| Limit | Kind | Today | Unit | Source |
|---|---|---|---|---|
| Resistance to treatment: laboratory-confirmed bacterial infections that were resistant, worldwide (about one in six; resistance rose in over 40% of monitored antibiotics from 2018 to 2023, by 5-15% a year on average) | Physical | – | about 1 in 6 infections (2023) | ^[6] |
| Number of 6-APA manufacturing sites in the world, of which five are in China | Engineering | 7 | sites (2026 think-tank report) | ^[2] |
| Finished dosage form capacity of Sandoz's Kundl site (company statement) | Engineering | 240 million | packages per year | ^[15] |

as of 2026-11-14

#### Science it relies on

The science principles it works by or is limited by
 Relies on

- [Antibiosis](https://www.materialinsights.org/science/antibiosis/) One microbe's product stops another microbe growing; antibiotic medicines apply that to bacteria in the body.

as of 2026-11-14

#### Sources

1. [New global guidance aims to curb antibiotic pollution from manufacturing](https://www.who.int/news/item//03-09-2024-new-global-guidance-aims-to-curb-antibiotic-pollution-from-manufacturing) World Health Organization, 2024, news release of 3 September 2024
2. [Foreign control of antibiotic supply: American and European import reliance and systemic vulnerabilities (Report No. 2026/06)](https://www.geostrategy.org.uk/research/foreign-control-of-antibiotic-supply/) Council on Geostrategy with the Coalition for a Prosperous America, 2026, think-tank report by Andrew Rechenberg (economist, Coalition for a Prosperous America, an advocacy group) and Patrick Triglavcanin (Council on Geostrategy); ISBN 978-1-917893-22-0; no publication month, no method section and no footnotes for the figures
3. [WHO warns of widespread resistance to common antibiotics worldwide](https://www.paho.org/en/news/13-10-2025-who-warns-widespread-resistance-common-antibiotics-worldwide) World Health Organization (PAHO copy), 2025, 13 October 2025; Global Antibiotic Resistance Surveillance Report 2025
4. [Antibiotics most responsible for drug resistance are overused - WHO report](https://www.who.int/news/item/29-04-2025-antibiotics-most-responsible-for-drug-resistance-are-overused---who-report) World Health Organization, 2025, news release of 29 April 2025; 2022 data
5. [Amoxicillin Dispersible Tablets: Market and Supply Update](https://www.unicef.org/supply/media/511/file/amoxicillin-dispersible-tablets-market-and-supply-update.pdf) UNICEF Supply Division, 2018, May 2018; Tables 1, 3 and 4
6. [Sandoz opens antibiotic production facility in Austria](https://chemanager-online.com/en/news/sandoz-opens-antibiotic-production-facility-in-austria) CHEManager International, 2024, 26 March 2024; company claims reported by a trade publication
7. [Aurobindo Pharma, KAPL get approval for promotion of manufacturing bulk drugs](https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-kapl-get-approval-for-promotion-of-manufacturing-bulk-drugs-73830) Medical Dialogues, 2021, 24 January 2021, by Ruchika Sharma, citing PTI and a Ministry of Chemicals and Fertilizers statement
8. [Rational Use Of Antibiotics For Limiting Antimicrobial Resistance: CDSCO lists down steps for Pharma cos, chemists and drug controllers](https://business.medicaldialogues.in/rational-use-of-antibiotics-for-limiting-antimicrobial-resistance-cdsco-lists-down-steps-for-pharma-cos-chemists-and-drug-controllers) Medical Dialogues, 2019, 26 December 2019, Medical Dialogues Bureau; secondhand report of a CDSCO notice
9. [NPPA Hikes Prices of Key Antibiotics Azithromycin, Amoxicillin Clavulanic Acid](https://medicaldialogues.in/news/industry/pharma/nppa-hikes-prices-of-key-antibiotics-azithromycin-amoxicillin-clavulanic-acid-143145) Medical Dialogues, 2025, 12 February 2025, by Farhat Nasim; reports the review order dated 4 October 2024
10. [The environmental impact of antibiotics](https://ipu.ie/the-environmental-impact-of-antibiotics) Irish Pharmacy Union (IPU Review; Ellen Martin, HSE AMRIC team), 2025, May 2025; review article citing Taylor et al. (2024)

## Other sections

- [Summary](https://www.materialinsights.org/products/p_antibiotic_medicines/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-bom/index.md)
- [Use case](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-evolution/index.md)
- [Interventions](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-interventions/index.md)
